Previous Close | 50.21 |
Open | 50.47 |
Bid | 49.56 x 100 |
Ask | 51.60 x 200 |
Day's Range | 50.47 - 50.47 |
52 Week Range | 32.69 - 52.69 |
Volume | |
Avg. Volume | 105,241 |
Market Cap | 1.009B |
Beta (5Y Monthly) | 0.68 |
PE Ratio (TTM) | 97.06 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.24 (0.48%) |
Ex-Dividend Date | Apr 26, 2024 |
1y Target Est | N/A |
LANCASTER, Calif., May 15, 2024--Simulations Plus announced the release of the completely redesigned GastroPlusX (GPX), the next generation PBPK/PBBM modeling & simulation software.
LANCASTER, Calif., April 04, 2024--Simulations Plus announced the US FDA has again renewed licenses to its DILIsym QST software to support informed decision-making in drug approvals.
LANCASTER, Calif., April 03, 2024--Simulations Plus today reported earnings for its second quarter of fiscal year 2024. Total revenue for the quarter increased 16% to $18.3 million.